The progress of ABCG2 in tumor of digestive system

Xicheng WANG,Zhiwei SUN,Lin SHEN

DOI: https://doi.org/10.3969/j.issn.1006-5709.2012.07.025

2012-01-01

Abstract:Many tumors fail to respond to chemotherapy by acquiring MDR(multiple drug resistance)in clinic.The phenotype of MDR has been correlated with the presence of MDR transporters that actively transport drugs out of the cell.ABCG2 is a member of the ATP binding cassette(ABC) superfamily,and it function is as a pump to translocate several cytotoxic drugs,including topotecan and irinotecan.However,the high-resolution structure of ABCG2 and its interaction with a variety of substrates are still unclear.Here,we reviewed recent studies on ABCG2 expression pattern,structure,function and its relation to gastrointestinal cancers.Several studies have indicated that ABCG2 might play a critical role of MDR in esophageal cancer,stomach cancer and colon cancer and negatively affect patient prognosis.Meanwhile,the single nucleotide polymorphisms(SNPs)of ABCG2 gene have been suggested to influence ABCG2 expression,location and transport activity.These changes might be associated with MDR in cancer cells and serve as a poor prognostic marker.